PD Dr. Arne Wieser (right), Division of Infectious Diseases and Tropical...
PD Dr. Arne Wieser (right), Division of Infectious Diseases and Tropical Medicine, LMU University Hospital Munich, and Prof. Dr. Christoph Haisch, Lasers and Microparticles Lab, Technical University of Munich.

© LMU University Hospital Munich

UV-C barrier against aerosols

An 'invisible wall' to keep out SARS-CoV-2

Despite of thorough precautionary measures, virus-contaminated aerosols still pose a serious problem indoors. An invisible protective wall of UV-C light developed by researchers at the Division of Infectious Diseases and Tropical Medicine at the LMU University Hospital Munich and the Technical University of Munich (TUM) could provide a solution and reliably curb the spread of viruses and other pathogens in rooms in the future while allowing total freedom of movement.

A research team from the Division of Infectious Diseases and Tropical Medicine at the LMU University Hospital Munich and the Technical University of Munich, in cooperation with the start-up Smart United GmbH, has developed an invisible protective “wall” made of UV-C light. In their study, published as a preprint on medRxiv, the researchers were able to demonstrate that the UV-C virus barrier they developed can prevent the spread of airborne pathogens indoors by killing the pathogens traveling along on the aerosol particles. The protection rate was verified using model organisms, including E. coli, S. aureus, and a coronavirus. Inactivation rates of over 99 percent were achieved at air velocities of 10cm/s. "Our system can be suspended from the ceiling like a lamp to subdivide rooms. The UV-C light radiates downward in a focused manner. As with a protective curtain, pathogens are inactivated as soon as they 'float through' the barrier while piggybacking on aerosol particles," explains PD Dr. Andreas Wieser, a specialist in microbiology, virology and infectious disease epidemiology at the Division of Infectious Diseases and Tropical Medicine at the LMU University Hospital Munich.

Recommended article

Professor Christoph Haisch from the Department of Analytical Chemistry and Water Chemistry at the Technical University of Munich adds: "In addition, the system with its patented protective mechanism disinfects breathing air in the room by drawing it in and slowly blowing it into the light-exposed area of the UV-C light wall. This, in combination with the direct barrier effect of the light wall, effectively prevents the accumulation of infectious aerosols in the room." 

Special shut-off devices ensure that the system's UV-C light poses no health risks. As soon as an object or body part enters the radiated area, the source is automatically switched off. This also applies when people pass through the light curtain, allowing total freedom of movement. Applicable requirements for occupational health and safety, including the strict exposure limits for UV radiation specified and other legal requirements, are fulfilled thanks to innovative specialized optics. In addition, the innovative LED light source and the special optics prevent ozone formation. 

The UV-C virus barrier can be used as an invisible room divider to segment large rooms into smaller 'virtual' air-insulated rooms. This allows the system to be deployed as an essential part of aerosol hygiene concepts in rooms and buildings. "We are currently doing everything imaginable to bring our virus protection walls to market as quickly as possible," says Reiner Prohaska, Managing Director of the cooperation partner Smart United. "Alongside the scientific validation of the system, we have started preparing production with well-known suppliers in the automotive industry. Starting in early January, we will commence space planning with our first customers. In April, we will deliver the first UV-C light virus protection walls – with the goal of returning a piece of normality to people’s lives." 


Source: LMU University Hospital Munich

21.12.2021

Read all latest stories

Related articles

Photo

Thromboembolic misunderstandings

Covid-19, not vaccination, presents biggest blood clot risks

Researchers from the University of Oxford have announced the results of a study into thrombocytopenia (a condition with low platelet counts) and thromboembolic events (blood clots) following…

Photo

Variants of concern

Are Covid-19 vaccines still effective against Delta variant? New study says yes

Obtaining two vaccine doses remains the most effective way to ensure protection against the Covid-19 Delta variant of concern dominant in the UK today, according to a study from the University of…

Photo

Public health worldwide

Sharing Covid-19 vaccines between nations: a mathematical approach

New research from the University of Oxford and the UK Centre for Ecology & Hydrology uses mathematical modelling to determine the most equitable way to share vaccines between nations. Vaccines…

Related products

Beckman Coulter – SARS-CoV-2 Assays

Immunoassays

Beckman Coulter – SARS-CoV-2 Assays

Beckman Coulter Diagnostics
Lifotronic  SARS-CoV-2 Antibody Detection Kit

Immunoassays

Lifotronic SARS-CoV-2 Antibody Detection Kit

Lifotronic Technology Co., Ltd
Lifotronic – SARS-CoV-2 Antigen

Immunoassays

Lifotronic – SARS-CoV-2 Antigen

Lifotronic Technology Co., Ltd
Lifotronic – SARS-CoV-2 Nucleic Acid Detection Kit

Detection

Lifotronic – SARS-CoV-2 Nucleic Acid Detection Kit

Lifotronic Technology Co., Ltd
Subscribe to Newsletter